Welcome to LookChem.com Sign In|Join Free
  • or
Benzenemethanamine, 4-ethynyl(9CI), also known as (4-Ethynylphenyl)methanamine, is an organic compound with a unique structure that features a benzene ring with an ethynyl group and an amino group attached to the side chain. Benzenemethanamine, 4-ethynyl(9CI) is characterized by its potential for chemical modifications and applications in various fields due to its versatile molecular structure.

197844-23-8

Post Buying Request

197844-23-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

197844-23-8 Usage

Uses

Used in Pharmaceutical Industry:
Benzenemethanamine, 4-ethynyl(9CI) is used as a key intermediate compound for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Polymer Industry:
In the polymer industry, Benzenemethanamine, 4-ethynyl(9CI) is used in the preparation of polymer-modified triazolylamides. These modified triazolylamides are utilized as implantable elements, which can be beneficial in various medical applications, such as orthopedic implants or drug delivery systems.
Used in Chemical Synthesis:
Benzenemethanamine, 4-ethynyl(9CI) serves as a versatile building block in chemical synthesis, allowing for the creation of a wide range of compounds with diverse applications. Its ethynyl group can be further functionalized, making it a valuable component in the synthesis of various organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 197844-23-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,7,8,4 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 197844-23:
(8*1)+(7*9)+(6*7)+(5*8)+(4*4)+(3*4)+(2*2)+(1*3)=188
188 % 10 = 8
So 197844-23-8 is a valid CAS Registry Number.

197844-23-8Downstream Products

197844-23-8Relevant academic research and scientific papers

N2-Substituted 2′-Deoxyguanosine Triphosphate Derivatives as Selective Substrates for Human DNA Polymerase κ

Gowda, A. S. Prakasha,Lee, Marietta,Spratt, Thomas E.

supporting information, p. 2628 - 2631 (2017/02/26)

N2-Alkyl-2′-deoxyguanosine triphosphate (N2-alkyl-dGTP) derivatives with methyl, butyl, benzyl, or 4-ethynylbenzyl substituents were prepared and tested as substrates for human DNA polymerases. N2-Benzyl-dGTP was equal to

Chemo- and Site-Selective Alkyl and Aryl Azide Reductions with Heterogeneous Nanoparticle Catalysts

Udumula, Venkatareddy,Nazari, S. Hadi,Burt, Scott R.,Alfindee, Madher N.,Michaelis, David J.

, p. 4423 - 4427 (2016/07/12)

Site-selective modification of bioactive natural products is an effective approach to generating new leads for drug discovery. Herein, we show that heterogeneous nanoparticle catalysts enable site-selective monoreduction of polyazide substrates for the generation of aminoglycoside antibiotic derivatives. The nanoparticle catalysts are highly chemoselective for reduction of alkyl and aryl azides under mild conditions and in the presence of a variety of easily reduced functional groups. High regioselectivity for monoazide reduction is shown to favor reduction of the least sterically hindered azide. We hypothesize that the observed selectivity is derived from the greater ability of less-hindered azide groups to interact with the surface of the nanoparticle catalyst. These results are complementary to previous Staudinger reduction methods that report a preference for selective reduction of electronically activated azides.

Weak interactions dominating the supramolecular self-assembly in a salt: A designed single-crystal-to-single-crystal topochemical polymerization of a terminal aryldiacetylene

Li, Zhong,Fowler, Frank W.,Lauher, Joseph W.

supporting information; experimental part, p. 634 - 643 (2009/06/18)

Single-crystal-to-single-crystal (SCSC) topochemical polymerizations of diacetylenes can yield nearly defect-free conjugated polymer crystals unattainable by other methods. Aryl-substituted diacetylenes with their potentially greater conjugation have been targeted for years, but until now no one has reported a SCSC polymerization of any aryl-substituted diacetylene. This is presumably due to the rigidity of such diaryl-substituted monomers as well as the lack of control over the supramolecular structure. To address this problem, the polymerization of a terminal phenyldiacetylene was targeted. It was assumed that a terminal diacetylene should demonstrate greater flexibility in the solid state. To establish the necessary (~4.9 A) repeat distance, commensurate with the repeat distance in the polymer, a host-guest system was designed. The chosen diacetylene guest, the amine DABzNH2, was to be crystallized with the oxalamide dicarboxylic acid host, H2og. The plan required a segregation of the hydrogen bonds, amide-amide hydrogen bonds to establish the 4.9 A spacing, and the carboxylate to ammonium ion hydrogen bonds to organize the guest. Prior to carrying out the diacetylene synthesis a series of model salts were studied. Consistent with the hydrophobic effect it was found that amines with large "greasy" substituents assembled according to the design. Once the model studies established that weak interactions could dominate the supramolecular structure of a salt, the actual design was put to the test. The targeted guest, DABzNH2, was synthesized and crystals of the host-guest salt (DABzNH3) 2og were prepared. The resulting crystal structure was in complete accordance with the design. A SCSC polymerization was achieved by a slow annealing treatment lasting about three months. The crystal structure of the resulting polymer not only confirmed the first example of a poly(aryldiacetylene) single crystal, it also revealed an unexpected reaction pathway that shows a major movement involving the rigid aromatic substituent.

Lacosamide isothiocyanate-based agents: Novel agents to target and identify lacosamide receptors

Ki, Duk Park,Morieux, Pierre,Salomé, Christophe,Cotten, Steven W.,Reamtong, Onrapak,Eyers, Claire,Gaskell, Simon J.,Stables, James P.,Liu, Rihe,Kohn, Harold

supporting information; experimental part, p. 6897 - 6911 (2010/04/24)

(R)-Lacosamide ((R)-2, (R)-N-benzyl 2-acetamido-3-methoxypropionamide) has recently gained regulatory approval for the treatment of partial-onset seizures in adults.Whole animal pharmacological studies have documented that (R)-2 function is unique. A robust strategy is advanced for the discovery of interacting proteins associated with function and toxicity of (R)-2 through the use of (R)-2 analogues, 3, which contain "affinity bait (AB)" and "chemical reporter (CR)" functional groups. In 3, covalent modification of the interacting proteins proceeds at the AB moiety, and detection or isolation of the selectively captured protein occurs through the bioorthogonal CR group upon reaction with an appropriate probe. We report the synthesis, pharmacological evaluation, and interrogation of the mouse soluble brain proteome using 3 where the AB group is an isothiocyanate moiety. One compound, (R)-N-(4-isothiocyanato)benzyl 2-acetamido-3-(prop-2-ynyloxy) propionamide ((R)-9), exhibited excellent seizure protection in mice, and like (R)-2, anticonvulsant activity principally resided in the (R)-stereoisomer. Several proteins were preferentially labeled by (R)-9 compared with (S)-9, including collapsin response mediator protein 2. 2009 American Chemical Society.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 197844-23-8